Skip to content

Opus - III Contact Lenses

by Wesley Jessen Corp.

PMA P820074

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P820074↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP820074 Date25 Jun 1985ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Lens, contact (other material) - daily
PMA Number
FDA Product Code
HQD
Device Class
Class II
Regulation
21 CFR Part 886.5916
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved
PMA Supplement
S004

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Opus-III Contact Lenses are classified as daily-use contact lenses made from other materials, as defined by the nomenclature authority. These soft, disposable lenses are designed for single-day wear to correct refractive errors and improve visual acuity in patients with mild to moderate myopia or hyperopia.

These lenses are supplied as single-use, non-sterile devices intended for ophthalmic use only. They are regulated under FDA Premarket Approval (PMA) with PMA number P820074 and fall under device class II (HQD product code). Storage and handling must comply with standard ophthalmic contact lens protocols to ensure patient safety and device integrity.

Other devices from Wesley Jessen Corp.

See all devices from Wesley Jessen Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Opus-III Contact Lenses intended for extended wear or daily use only?

    The Opus-III Contact Lenses are explicitly designed for single-day wear only, as stated in the description. They are classified as daily-use contact lenses and are not intended for overnight or extended wear. This aligns with standard disposable contact lens guidelines to ensure patient safety and comfort.

  • How should I store the Opus-III Contact Lenses before use, and are they sterile?

    The Opus-III Contact Lenses are non-sterile and must be stored and handled according to standard ophthalmic contact lens protocols. Since they are single-use, they should be kept in a clean, dry environment away from direct sunlight or extreme temperatures until use. Always follow manufacturer instructions for proper storage to maintain device integrity.

  • What regulatory pathway was followed for the approval of the Opus-III Contact Lenses?

    The Opus-III Contact Lenses were approved through the FDA Premarket Approval (PMA) process, with PMA number P820074. This pathway is typically used for higher-risk medical devices, and the product falls under device class II with the product code HQD. The approval was granted in 1984, as indicated in the submission records.

  • Are there multiple sizes or models available for the Opus-III Contact Lenses, and how are they differentiated?

    While the provided data does not specify exact sizes or models in detail, the Opus-III Contact Lenses are categorized under FDA’s generic name ‘Lens, contact (other material) - daily’, which implies they are designed to correct refractive errors like myopia or hyperopia. The OpenFDA registration numbers suggest multiple FEI (Firm Establishment Identifier) entries, which may correlate to different lot batches or variations in prescription strengths. For precise sizing or model details, refer to the manufacturer’s labeling or product documentation.